The NK-cell-activating receptor NKG2D recognizes multiple ligands, such as UL-16-binding proteins, major histocompatibility complex class I chain-related A, and MICB, which are present in increased abundance on the surface of viral-infected cells and many tumor cells. Here, NCR1 is linked to neoplasm.